Literature DB >> 30214555

A TOP2A-derived cancer panel drives cancer progression in papillary renal cell carcinoma.

Mushi Ye1, Zhuobin He2, Wei Dai3, Zhuo Li1, Xiaojun Chen1, Jianjun Liu1.   

Abstract

The aim of the present study was to investigate the function of the DNA topoisomerase IIα (TOP2A) gene and its associated genes in the progression of papillary renal cell carcinoma (PRCC). Online cancer databases, including cBioportal, Oncomine, OncoLnc and Search Tool for the Retrieval of Interacting Genes/Proteins were used to analyze the TOP2A gene expression profile, function and regulation network in PRCC. The genes that were significantly co-expressed or mutually exclusively expressed with TOP2A were identified. The genes co-expressed with TOP2A were defined as a 'TOP2A-cancer panel', which cooperatively promotes PRCC progression. This gene panel performed well in predicting the prognosis of PRCC. In addition, the TOP2A-cancer panel significantly affected the outcome of PRCC compared with clear cell renal cell carcinoma (CCRCC). The protein-protein interaction network of all genes associated with TOP2A was also generated. This interaction network may provide foundation for the additional investigation of TOP2A. Integrative understating of the TOP2A-cancer panel may result in a novel avenue for treatment intervention in PRCC.

Entities:  

Keywords:  DNA topoisomerase IIα; cancer panel; papillary renal cell carcinoma

Year:  2018        PMID： 30214555      PMCID： PMC6126182          DOI： 10.3892/ol.2018.9179

Source DB:  PubMed          Journal:  Oncol Lett        ISSN： 1792-1074            Impact factor:   2.967


  36 in total

Review 1.  Renal cancer.

Authors:  Umberto Capitanio; Francesco Montorsi
Journal:  Lancet       Date:  2015-08-25       Impact factor: 79.321

2.  TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin: TOP2A as marker of response to PLD in ovarian cancer.

Authors:  J Erriquez; P Becco; M Olivero; R Ponzone; F Maggiorotto; A Ferrero; M S Scalzo; E M Canuto; A Sapino; L Verdun di Cantogno; P Bruna; M Aglietta; M F Di Renzo; G Valabrega
Journal:  Gynecol Oncol       Date:  2015-06-20       Impact factor: 5.482

3.  Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.

Authors:  Alexander S Parker; Jeanette E Eckel-Passow; Daniel Serie; Tracy Hilton; Mansi Parasramka; Richard W Joseph; Kevin J Wu; John C Cheville; Bradley C Leibovich
Journal:  Eur Urol       Date:  2013-12-25       Impact factor: 20.096

4.  A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.

Authors:  Stephen E Lincoln; Yuya Kobayashi; Michael J Anderson; Shan Yang; Andrea J Desmond; Meredith A Mills; Geoffrey B Nilsen; Kevin B Jacobs; Federico A Monzon; Allison W Kurian; James M Ford; Leif W Ellisen
Journal:  J Mol Diagn       Date:  2015-07-22       Impact factor: 5.568

5.  TMAP/CKAP2 is essential for proper chromosome segregation.

Authors:  Kyung Uk Hong; Eunhee Kim; Chang-Dae Bae; Joobae Park
Journal:  Cell Cycle       Date:  2009-01-15       Impact factor: 4.534

6.  Current Treatment Landscape of Advanced Papillary Renal Cancer.

Authors:  Brian Shuch; Andrew W Hahn; Neeraj Agarwal
Journal:  J Clin Oncol       Date:  2017-07-24       Impact factor: 44.544

7.  HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.

Authors:  George Fountzilas; Christos Valavanis; Vassiliki Kotoula; Anastasia G Eleftheraki; Konstantine T Kalogeras; Olympia Tzaida; Anna Batistatou; Ralf Kronenwett; Ralph M Wirtz; Mattheos Bobos; Eleni Timotheadou; Nikolaos Soupos; George Pentheroudakis; Helen Gogas; Dimitrios Vlachodimitropoulos; Genovefa Polychronidou; Gerasimos Aravantinos; Angelos Koutras; Christos Christodoulou; Dimitrios Pectasides; Petroula Arapantoni
Journal:  J Transl Med       Date:  2012-01-12       Impact factor: 5.531

8.  Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.

Authors:  Holly LaDuca; A J Stuenkel; Jill S Dolinsky; Steven Keiles; Stephany Tandy; Tina Pesaran; Elaine Chen; Chia-Ling Gau; Erika Palmaer; Kamelia Shoaepour; Divya Shah; Virginia Speare; Stephanie Gandomi; Elizabeth Chao
Journal:  Genet Med       Date:  2014-04-24       Impact factor: 8.822

9.  Human TPX2 is required for targeting Aurora-A kinase to the spindle.

Authors:  Thomas A Kufer; Herman H W Silljé; Roman Körner; Oliver J Gruss; Patrick Meraldi; Erich A Nigg
Journal:  J Cell Biol       Date:  2002-08-12       Impact factor: 10.539

Review 10.  The Role of Endocrine G Protein-Coupled Receptors in Ovarian Cancer Progression.

Authors:  Qingyu Zhang; Nadine Ellen Madden; Alice Sze Tsai Wong; Billy Kwok Chong Chow; Leo Tsz On Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-07       Impact factor: 5.555
View more
  5 in total

1.  Identification of Potential Crucial Genes Associated With the Pathogenesis and Prognosis of Endometrial Cancer.

Authors:  Li Liu; Jiajing Lin; Hongying He
Journal:  Front Genet       Date:  2019-04-26       Impact factor: 4.599

2.  iTRAQ‑based proteomics analysis of the therapeutic effects of combined anticancer bioactive peptides and oxaliplatin on gastric cancer cells.

Authors:  Yanan Xu; Xian Li; Xiulan Su
Journal:  Oncol Rep       Date:  2019-11-11       Impact factor: 3.906

3.  Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis.

Authors:  Ping Wu; Tingting Xiang; Jing Wang; Run Lv; Shaoxin Ma; Limei Yuan; Guangzhen Wu; Xiangyu Che
Journal:  BMC Med Genomics       Date:  2021-10-07       Impact factor: 3.063

4.  Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma.

Authors:  Haiping Zhang; Jian Zou; Ying Yin; Bo Zhang; Yaling Hu; Jingjing Wang; Huijun Mu
Journal:  PeerJ       Date:  2019-11-26       Impact factor: 2.984

5.  Influence of gene expression on survival of clear cell renal cell carcinoma.

Authors:  Anders Berglund; Ernest K Amankwah; Young-Chul Kim; Philippe E Spiess; Wade J Sexton; Brandon Manley; Hyun Y Park; Liang Wang; Jad Chahoud; Ratna Chakrabarti; Chang D Yeo; Hung N Luu; Giuliano D Pietro; Alexander Parker; Jong Y Park
Journal:  Cancer Med       Date:  2020-09-28       Impact factor: 4.452
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.